Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neoadjuvant Hormonal Therapy and Radical Prostatectomy for Locally Advanced Prostate Cancer.

Pansadoro1, Sternberg

  • 1Department of Urology, San Giovanni Hospital, Rome, Italy.

Molecular Urology
|June 14, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On Yellow Fever.

Transactions. Epidemiological Society of London·2018
Same author

The contribution of the Army to the fight against venereal disease in the United States after the war.

La Prophylaxie antivenerienne·2010
Same author

Difficulty in defecation; mass in buttock [benign teratoid tumor].

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same author

Anorexia; vomiting; convulsions [congenital urethral valve].

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same author

Cyanosis and retarded development [atresia of pulmonary artery: absence of pulmonary valve; survival to 3-1/2 years].

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same author

Generalized swelling.

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same journal

Status and prospects of gene therapy for urologic cancer. First Meeting of the Japanese Society for Urological Gene Therapy. November 20, 1999. Okayama, Japan.

Molecular urology·2002
Same journal

Application of conditionally replicating herpes vector for gene therapy treatment of urologic neoplasms.

Molecular urology·2002
Same journal

Tissue-specific promoters in gene therapy for the treatment of prostate cancer.

Molecular urology·2002
Same journal

Suicide gene therapy for urogenital cancer: current outcome and prospects.

Molecular urology·2002
Same journal

Hammerhead ribozymes as therapeutic agents for bladder cancer.

Molecular urology·2002
Same journal

Application of antisense technology to urologic cancers.

Molecular urology·2002
See all related articles

Neoadjuvant hormonal therapy may shrink tumors in advanced prostate cancer, but its long-term benefits and impact on survival are unclear. Current evidence suggests it is not recommended outside clinical trials due to side effects and costs.

Area of Science:

  • Oncology
  • Urology

Background:

  • Management of locally advanced prostate cancer is controversial.
  • High rates of positive margins in radical prostatectomy specimens necessitate improved treatment strategies.
  • Neoadjuvant hormonal therapy is being investigated to reduce tumor size before surgery.

Purpose of the Study:

  • To evaluate the effectiveness of neoadjuvant hormonal therapy in locally advanced prostate cancer.
  • To determine the impact of neoadjuvant hormonal therapy on tumor stage and patient survival.

Main Methods:

  • Review of nonrandomized and randomized clinical trials.
  • Analysis of tumor size reduction, tumor stage, and patient survival data.

Main Results:

  • Neoadjuvant hormonal therapy demonstrated reductions in primary tumor size in multiple trials.

Related Experiment Videos

  • The effect of neoadjuvant hormonal therapy on tumor stage and long-term patient survival remains unclear.

    • Conclusions:

    • While neoadjuvant hormonal therapy can reduce tumor size, its overall clinical benefit for locally advanced prostate cancer is not established.
    • Due to unclear long-term value, potential side effects, and increased costs, neoadjuvant hormonal therapy is not currently recommended outside of clinical research settings.